Gilead Sciences Inc. logo

GILD

Gilead Sciences Inc.

$143.72
-0.75%
Last updated 5:11 AM
Gilead Sciences, Inc logo

Gilead Sciences, Inc

Gilead Sciences, Inc is a Biotechnology company listed on NASDAQ NMS - GLOBAL MARKET.

Industry
Biotechnology
Exchange
NASDAQ NMS - GLOBAL MARKET
Market Cap
$178.2B
P/E Ratio
20.9
Cash on Hand
$7.6B(positive)
Shares Outstanding
1.24B shares
Currency
USD
Visit website →

About

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.

via Wikipedia →

Earnings (EPS)

QuarterEPS EstimateEPS Actual
Q2 2026$-7.38$-6.75
Q1 2026$1.95$2.03
Q4 2025$1.85$1.86
Q3 2025$2.17$2.47

Financial Highlights

The basics, explained simply — no finance degree required.

52-Week Range
$108.46 – $157.29

The lowest and highest price this stock has traded at over the past year.

Dividend Yield
3.98%

How much this stock pays you back each year, just for holding it — as a % of the share price.

Profit Margin
-10.6%

How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.

Revenue Growth
+5.5%

How much the company's sales grew compared to a year ago.

Volatility (Beta)
0.40

How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.

Analyst Insights

Analyst Consensus
Buy

Based on 37 analysts

Next Earnings
Oct 28, 2026

Insider Activity

Recent buys and sells by company executives and directors — publicly disclosed, as required by law.

WELTERS ANTHONY
Aug 26, 2026 • $60.67/share
Bought 7,718
WELTERS ANTHONY
Aug 26, 2026 • $148.31/share
Sold 3,118
WELTERS ANTHONY
Aug 26, 2026 • $148.82/share
Sold 4,600
WELTERS ANTHONY
Aug 26, 2026 • $61.35/share
Bought 10,282
WELTERS ANTHONY
Aug 26, 2026 • $148.24/share
Sold 3,402
WELTERS ANTHONY
Aug 26, 2026 • $148.82/share
Sold 6,880

Recent News